2022-2029年全球肿瘤学人工智能分析解决方案市场规模研究与预测,按组件、癌症类型和区域分析。
市场调查报告书
商品编码
1269708

2022-2029年全球肿瘤学人工智能分析解决方案市场规模研究与预测,按组件、癌症类型和区域分析。

Global AI In Oncology for Analytical Solutions Market Size study & Forecast, by Component by Cancer Type and Regional Analysis, 2022-2029

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021年,全球人工智能在肿瘤学的分析解决方案市场价值约为4519.9亿美元,预计在2022-2029年的预测期内,将以超过35.50%的健康增长率增长。人工智能在癌症实践中的使用提供了临床决策支持,主要用于处理癌症检测、癌症诊断和筛查的医疗数据,或对病人预后的描述,并优化护理服务和临床操作。癌症发病率的上升正在推动这个行业。这是因为世界各地的病例数量正在迅速增加。市场的主要驱动因素是癌症发病率的上升,对远程医疗和远程护理的需求不断增加。此外,人工智能在肿瘤学分析解决方案方面的进步,采用人工智能进行疾病诊断,在2022-2029年的预测期内为市场创造了有利可图的增长机会。

癌症是全世界死亡的一个主要原因,根据世界卫生组织的数据,仅在2020年就有大约1000万人死亡,占所有死亡人数的近六分之一。世界卫生组织补充说,吸烟、饮酒、高体重指数和缺乏体育锻炼等因素会导致癌症。此外,患有肺癌的人感染COVID-19的机会更高。根据2022年12月发布的一份报告,在2018年1月1日至2022年7月2日期间,美国疾病控制和预防中心的国家生命统计系统中提到的死亡原因包括癌症。根据审查的数据,平均每周约有13,000例与癌症有关的死亡报告,在2018年和2019年,这种疾病是90%的病例的主要原因,2020年有88%的病例,2021年有87%的病例。然而,在这些困难的情况下,当代AI和ML技术有可能改善病人的诊断、护理和治疗。大流行期间积压的癌症成像问题用人工智能解决了,这减少了医务人员的负担。然而,在2022-2029年的整个预测期内,AI In Oncology For Analytical Solutions的高成本扼杀了市场增长。

全球AI In Oncology for Analytical Solutions市场研究考虑的主要地区包括亚太、北美、欧洲、拉美和世界其他地区。2021年,北美洲控制了行业的份额。这种扩张归因于数字基础设施的可用性和政府的支持政策等因素。由于政府报销的增加,肿瘤学服务预计将在该地区变得更受欢迎。亚太地区预计将在2023年至2030年期间经历最快的增长。这一发展有几个因素,包括印度和日本等国家老年人口的增加,以及医院和诊断中心对数字技术的扩大使用,都可以归功于此。

该研究的目的是确定近年来不同细分市场和国家的市场规模,并对未来几年的价值进行预测。该报告旨在将研究涉及的国家内的行业的定性和定量方面都纳入其中。

该报告还提供了关于关键方面的详细信息,如驱动因素和挑战,这将确定市场的未来增长。此外,它还纳入了微观市场的潜在机会,供利益相关者投资,以及对竞争格局和主要参与者的组件产品的详细分析。.

目录

第一章:执行摘要

  • 市场简介
  • 2019-2029年全球和细分市场的估计和预测
    • 2019-2029年,按地区划分,AI在肿瘤学分析解决方案中的应用市场
    • 2019-2029年,肿瘤学人工智能分析解决方案市场,按组件划分
    • 2019-2029年,肿瘤学人工智能分析解决方案市场,按癌症类型划分
  • 主要趋势
  • 估算方法
  • 研究假设

第二章:全球肿瘤学人工智能分析解决方案市场的定义和范围

  • 本研究的目的
  • 市场定义和范围
    • 研究的范围
    • 行业演变
  • 研究中考虑的年份
  • 货币兑换率

第三章:全球AI in Oncology for Analytical Solutions市场动态

  • 肿瘤学人工智能分析解决方案的市场影响分析(2019-2029年)
    • 市场驱动力
      • 癌症的发病率不断上升
      • 对远程医疗和远程护理的需求不断增加
    • 市场挑战
      • 肿瘤学人工智能分析解决方案的成本高昂
    • 市场机会
      • 肿瘤学人工智能在分析解决方案方面的进展
      • 采用人工智能进行疾病诊断

第四章:全球AI in Oncology for Analytical Solutions市场行业分析

  • 波特的5力模型
    • 供应商的议价能力
    • 买方的讨价还价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争性的竞争
  • 波特五力模型的未来方法(2019-2029年)
  • PEST分析
    • 政治因素
    • 经济
    • 社会
    • 技术
  • 投资采用模式
  • 分析师建议和结论
  • 最佳投资机会
  • 最佳策略

第五章:风险评估:COVID-19的影响

  • 评估COVID-19对行业的整体影响
  • COVID-19前和COVID-19后的市场情况

第六章:全球AI在肿瘤学中的分析解决方案市场,按组件划分

  • 市场简介
  • 全球肿瘤学人工智能分析解决方案市场,按组件,性能-潜力分析
  • 2019-2029年全球肿瘤学人工智能分析解决方案的市场估计和预测,按组件划分
  • 肿瘤学人工智能分析解决方案市场,細項分析
    • 数据许可服务
    • 软件解决方案
    • 分析和其他服务

第7章 :全球肿瘤学人工智能分析解决方案市场,按癌症类型划分

  • 市场简介
  • 按癌症类型分類的全球肿瘤学人工智能分析解决方案市场,表现 - 潜力分析
  • 2019-2029年全球AI肿瘤学分析解决方案市场按癌症类型的估计和预测
  • 肿瘤学人工智能分析解决方案市场,細項分析
    • 乳腺癌
    • 肺癌
    • 前列腺癌
    • 结直肠癌
    • 脑瘤
    • 肾癌
    • 非霍奇金淋巴瘤
    • 膀胱癌

第八章:全球肿瘤学人工智能分析解决方案市场,区域分析

  • 肿瘤学人工智能分析解决方案市场,区域市场简介
  • 北美洲
    • 美国
      • 2019-2029年组件细分的估计和预测
      • 癌症类型细分估计和预测,2019-2029年
    • 加拿大
  • 欧洲肿瘤学人工智能分析解决方案市场简介
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 亚太地区AI在肿瘤学中的分析解决方案市场简介
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉美肿瘤学人工智能分析解决方案市场简介
    • 巴西
    • 墨西哥
  • 世界其他地区

第九章:竞争情报

  • 顶级市场战略
  • 公司简介
    • Azra AI
      • 关键信息
      • 概况
      • 财务(取决于数据的可用性)
      • 产品摘要
      • 近期发展情况
    • International Business Machines Corporation
    • Siemens Healthineers
    • Intel Corporation
    • GE Healthcare
    • NVIDIA Corporation
    • Digital Diagnostics Inc.
    • Concert.AI
    • Median Technologies
    • Path AI

第十章 :研究过程

  • 研究过程
    • 资料探勘
    • 数据分析
    • 市场评估
    • 验证
    • 出版
  • 研究属性
  • 研究假设

Global AI In Oncology for Analytical Solutions Market is valued at approximately USD 451.99 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 35.50% over the forecast period 2022-2029. The use of AI in cancer practice offers to supply clinical decision support majorly for processing medical data for cancer detection, cancer diagnosis and screening, or characterization of patient prognosis, and optimizing care delivery and clinical operations. The rising incidence of cancer is driving the industry. This is because the number of instances around the world is increasing quickly. The major driving factor for the market the is rising prevalence of cancer, the growing demand for telemedicine and remote care. Moreover, advancements in AI in oncology for analytical solutions, the adoption of AI for disease diagnosis is creating a lucrative growth opportunity for the market over the forecast period 2022-2029.

Cancer is a major cause of death worldwide, and according to the WHO, it was responsible for roughly 10 million deaths in 2020 alone, or nearly one-sixth of all deaths. The World Health Organization added that factors like tobacco use, alcohol consumption, a high body mass index, and a lack of physical exercise can cause cancer. Furthermore, individuals with lung cancer have a higher chance of contracting COVID-19. Among the causes of death mentioned in the National Vital Statistics System of the Centers for Disease Control and Prevention between January 1, 2018, and July 2, 2022, was cancer, according to a report released in December 2022. According to the data examined, there were approximately 13,000 cancer-related deaths reported weekly on average, with this illness being the primary cause in 90% of cases in 2018 and 2019, 88% of cases in 2020, and 87% of cases in 2021. However, in these difficult situations, contemporary AI and ML technologies have the potential to improve patient diagnosis, care, and treatment. The backlog of cancer imaging during the pandemic was addressed with artificial intelligence, which decreased the burden on the medical staff. However, the high cost of AI In Oncology For Analytical Solutions stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global AI In Oncology for Analytical Solutions Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2021, North America controlled the industry with a share. The expansion is ascribed to elements such as the availability of digital infrastructure and supportive governmental policies. Oncology services are anticipated to become more popular in the area as a result of increased government reimbursements. Asia Pacific is anticipated to experience the fastest increase between 2023 and 2030. Several factors, including the rising elderly population in nations such as India and Japan and the expanding use of digital technologies in hospitals and diagnostic centers, can be credited for this development.

Major market player included in this report are:

  • Azra AI
  • International Business Machines Corporation
  • Siemens Healthineers
  • Intel Corporation
  • GE Healthcare
  • NVIDIA Corporation
  • Digital Diagnostics Inc.
  • Concert.AI
  • Median Technologies
  • Path AI

Recent Developments in the Market:

  • A group of scientists from the National Institutes of Health and Global Good created a machine learning algorithm that can analyze digital pictures of the cervix in women in 2019.
  • The GI GeniusTM intelligent endoscopy module, which is driven by AI and aids healthcare professionals in the detection of colorectal cancer by improving visualization during colonoscopy, was introduced by Medtronic plc in August 2022 in India.

Global AI In Oncology for Analytical Solutions Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Component, Cancer Type, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Component offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Component:

  • Data Licensing Services
  • Software Solutions
  • Analytics and Other Services

By Cancer Type:

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Brain Tumor
  • Kidney Cancer
  • Non-Hodgkin Lymphoma
  • Bladder Cancer

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. AI In Oncology for Analytical Solutions Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. AI In Oncology for Analytical Solutions Market, by Component, 2019-2029 (USD Billion)
    • 1.2.3. AI In Oncology for Analytical Solutions Market, by Cancer Type, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global AI In Oncology for Analytical Solutions Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global AI In Oncology for Analytical Solutions Market Dynamics

  • 3.1. AI In Oncology for Analytical Solutions Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of cancer
      • 3.1.1.2. Growing demand for telemedicine and remote care
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of AI In Oncology for Analytical Solutions
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in AI in oncology for analytical solutions
      • 3.1.3.2. Adoption of AI for disease diagnosis

Chapter 4. Global AI In Oncology for Analytical Solutions Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global AI In Oncology for Analytical Solutions Market, by Component

  • 6.1. Market Snapshot
  • 6.2. Global AI In Oncology for Analytical Solutions Market by Component, Performance - Potential Analysis
  • 6.3. Global AI In Oncology for Analytical Solutions Market Estimates & Forecasts by Component 2019-2029 (USD Billion)
  • 6.4. AI In Oncology for Analytical Solutions Market, Sub Segment Analysis
    • 6.4.1. Data Licensing Services
    • 6.4.2. Software Solutions
    • 6.4.3. Analytics and Other Services

Chapter 7. Global AI In Oncology for Analytical Solutions Market, by Cancer Type

  • 7.1. Market Snapshot
  • 7.2. Global AI In Oncology for Analytical Solutions Market by Cancer Type, Performance - Potential Analysis
  • 7.3. Global AI In Oncology for Analytical Solutions Market Estimates & Forecasts by Cancer Type 2019-2029 (USD Billion)
  • 7.4. AI In Oncology for Analytical Solutions Market, Sub Segment Analysis
    • 7.4.1. Breast Cancer
    • 7.4.2. Lung Cancer
    • 7.4.3. Prostate Cancer
    • 7.4.4. Colorectal Cancer
    • 7.4.5. Brain Tumor
    • 7.4.6. Kidney Cancer
    • 7.4.7. Non-Hodgkin Lymphoma
    • 7.4.8. Bladder Cancer

Chapter 8. Global AI In Oncology for Analytical Solutions Market, Regional Analysis

  • 8.1. AI In Oncology for Analytical Solutions Market, Regional Market Snapshot
  • 8.2. North America AI In Oncology for Analytical Solutions Market
    • 8.2.1. U.S. AI In Oncology for Analytical Solutions Market
      • 8.2.1.1. Component breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Cancer Type breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada AI In Oncology for Analytical Solutions Market
  • 8.3. Europe AI In Oncology for Analytical Solutions Market Snapshot
    • 8.3.1. U.K. AI In Oncology for Analytical Solutions Market
    • 8.3.2. Germany AI In Oncology for Analytical Solutions Market
    • 8.3.3. France AI In Oncology for Analytical Solutions Market
    • 8.3.4. Spain AI In Oncology for Analytical Solutions Market
    • 8.3.5. Italy AI In Oncology for Analytical Solutions Market
    • 8.3.6. Rest of Europe AI In Oncology for Analytical Solutions Market
  • 8.4. Asia-Pacific AI In Oncology for Analytical Solutions Market Snapshot
    • 8.4.1. China AI In Oncology for Analytical Solutions Market
    • 8.4.2. India AI In Oncology for Analytical Solutions Market
    • 8.4.3. Japan AI In Oncology for Analytical Solutions Market
    • 8.4.4. Australia AI In Oncology for Analytical Solutions Market
    • 8.4.5. South Korea AI In Oncology for Analytical Solutions Market
    • 8.4.6. Rest of Asia Pacific AI In Oncology for Analytical Solutions Market
  • 8.5. Latin America AI In Oncology for Analytical Solutions Market Snapshot
    • 8.5.1. Brazil AI In Oncology for Analytical Solutions Market
    • 8.5.2. Mexico AI In Oncology for Analytical Solutions Market
  • 8.6. Rest of The World AI In Oncology for Analytical Solutions Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Azra AI
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. International Business Machines Corporation
    • 9.2.3. Siemens Healthineers
    • 9.2.4. Intel Corporation
    • 9.2.5. GE Healthcare
    • 9.2.6. NVIDIA Corporation
    • 9.2.7. Digital Diagnostics Inc.
    • 9.2.8. Concert.AI
    • 9.2.9. Median Technologies
    • 9.2.10. Path AI

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global AI In Oncology for Analytical Solutions Market, report scope
  • TABLE 2. Global AI In Oncology for Analytical Solutions Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global AI In Oncology for Analytical Solutions Market estimates & forecasts by Component 2019-2029 (USD Billion)
  • TABLE 4. Global AI In Oncology for Analytical Solutions Market estimates & forecasts by Cancer Type 2019-2029 (USD Billion)
  • TABLE 5. Global AI In Oncology for Analytical Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global AI In Oncology for Analytical Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global AI In Oncology for Analytical Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global AI In Oncology for Analytical Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global AI In Oncology for Analytical Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global AI In Oncology for Analytical Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global AI In Oncology for Analytical Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global AI In Oncology for Analytical Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global AI In Oncology for Analytical Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global AI In Oncology for Analytical Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global AI In Oncology for Analytical Solutions Market
  • TABLE 70. List of primary sources, used in the study of global AI In Oncology for Analytical Solutions Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global AI In Oncology for Analytical Solutions Market, research methodology
  • FIG 2. Global AI In Oncology for Analytical Solutions Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global AI In Oncology for Analytical Solutions Market, key trends 2021
  • FIG 5. Global AI In Oncology for Analytical Solutions Market, growth prospects 2022-2029
  • FIG 6. Global AI In Oncology for Analytical Solutions Market, porters 5 force model
  • FIG 7. Global AI In Oncology for Analytical Solutions Market, pest analysis
  • FIG 8. Global AI In Oncology for Analytical Solutions Market, value chain analysis
  • FIG 9. Global AI In Oncology for Analytical Solutions Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global AI In Oncology for Analytical Solutions Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global AI In Oncology for Analytical Solutions Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global AI In Oncology for Analytical Solutions Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global AI In Oncology for Analytical Solutions Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global AI In Oncology for Analytical Solutions Market, regional snapshot 2019 & 2029
  • FIG 15. North America AI In Oncology for Analytical Solutions Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe AI In Oncology for Analytical Solutions Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific AI In Oncology for Analytical Solutions Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America AI In Oncology for Analytical Solutions Market 2019 & 2029 (USD Billion)
  • FIG 19. Global AI In Oncology for Analytical Solutions Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable